Clinical significance of CD45 and CD200 expression in newly diagnosed multiple myeloma patients. [PDF]
Long X, Liu J, Hu R, Wang C, Fu Y.
europepmc +1 more source
[Expression and clinical significance of CCL17, CCL22, and CCR4 in newly diagnosed multiple myeloma]. [PDF]
Xiao ZF +5 more
europepmc +1 more source
[Minimal residual disease assessment and progress in multiple myeloma]. [PDF]
Zhou HX, Chen WM.
europepmc +1 more source
[Chinese expert consensus on diagnosis and treatment of high risk multiple myeloma (2024)]. [PDF]
Myeloma & Plasma Cell Disease Group +2 more
europepmc +1 more source
[Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping]. [PDF]
Wang YF +5 more
europepmc +1 more source
[BCMA chimeric antigen receptor T cells therapy re-treatment of a patient with recurrent/refractory IgD multiple myeloma: A case report and literature review]. [PDF]
Gu SN, Qiang WT, Lu J, Feng ZY, Du J.
europepmc +1 more source
[Chinese expert consensus on minimal residual disease detection in multiple myeloma based on bone marrow samples (2024)]. [PDF]
Experimental Diagnostic Group +4 more
europepmc +1 more source
[Cytoplasmic light-chain immunofluorescence combined with FISH in bone marrow smears to detect cytogenetic abnormalities in multiple myeloma]. [PDF]
Shi Y +6 more
europepmc +1 more source
[Correlation analysis of polyclonal plasma cell proportion in the bone marrow with clinical characteristics of patients with newly diagnosed multiple myeloma]. [PDF]
Long XL +8 more
europepmc +1 more source

